Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shanyang He
Observed names:
He, Shanyang,
SHAN-YANG HE,
Shan-Yang He,
Shan-yang He
Institutions:
Sun Yat-sen University,
The First Affiliated Hospital, Sun Yat-sen University,
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University,
South China University of Technology
show all 6
Observed institutions:
Sun Yat-sen University,
The First Affiliated Hospital, Sun Yat-sen University,
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University,
South China University of Technology
show all 6
ORCID:
0000-0002-9643-2849
Observed ORCID:
0000-0002-9643-2849
OpenAlex ID:
A5102924775
Single‐Cell Atlas of Human Ovaries Reveals The Role Of The Pyroptotic Macrophage in Ovarian Aging
2023
·
Chuanchuan Zhou
, Qi Guo
, et al.
·
Advanced Science
·
85
PDF
Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling
2015
·
Weiling He
, Shanyang He
, et al.
·
BMC Cancer
·
75
PDF
AEG-1 expression characteristics in human non-small cell lung cancer and its relationship with apoptosis
2013
·
Zun-fu Ke
, Xiaopeng Mao
, et al.
·
Medical Oncology
·
57
N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation
2024
·
Han Li
, Run Lin
, et al.
·
Molecular Cancer
·
39
PDF
Expression characteristics of astrocyte elevated gene-1 (AEG-1) in tongue carcinoma and its correlation with poor prognosis
2012
·
Zun-fu Ke
, Shanyang He
, et al.
·
Cancer Epidemiology
·
25
High histone H3K18 lactylation level is correlated with poor prognosis in epithelial ovarian cancer
2024
·
Jinyu Chao
, Guan-di Chen
, et al.
·
Neoplasma
·
20
PDF
MicroRNA-1297 inhibits metastasis and epithelial-mesenchymal transition by targeting AEG-1 in cervical cancer
2017
·
Zengyan Wang
, Shanyang He
, et al.
·
Oncology Reports
·
20
PDF
PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer
2021
·
Hongwei Shen
, Bing Liao
, et al.
·
Molecular Therapy — Oncolytics
·
17
Overexpression of glycosyltransferase 8 domain containing 2 confers ovarian cancer to CDDP resistance by activating FGFR/PI3K signalling axis
2021
·
Shuting Huang
, Suiying Liang
, et al.
·
Oncogenesis
·
14
PDF
PBOV1 correlates with progression of ovarian cancer and inhibits proliferation of ovarian cancer cells
2015
·
LAN WANG
, CHUN-HAO NIU
, et al.
·
Oncology Reports
·
11
PDF
Overexpression of RNF2 is positively associated with ovarian carcinoma aggressiveness and indicative of poor patient survival
2016
·
Xiao-Qing Li
, Wei-Peng He
, et al.
·
Oncotarget
·
10
PDF
Family with sequence similarity 46 member a confers chemo-resistance to ovarian carcinoma via TGF-β/Smad2 signaling
2022
·
Suiying Liang
, Yueyang Liu
, et al.
·
Bioengineered
·
9
Effectiveness and safety of niraparib as neoadjuvant therapy in advanced ovarian cancer with homologous recombination deficiency: NANT study protocol for a prospective, multicenter, exploratory, phase 2, single-arm study (041)
2022
·
Yang Yu
, Wei Zhang
, et al.
·
Gynecologic Oncology
·
7
Efficacy, safety, and biomarkers of neoadjuvant niraparib monotherapy in homologous recombination deficiency (HRD) advanced ovarian cancer: A prospective, multicenter, phase II, single-arm NANT study.
2024
·
Qing-lei Gao
, Dan Liu
, et al.
·
Journal of Clinical Oncology
·
6
PDF
High IGFL2 regulates ovarian cancer progression and the tumor immune microenvironment via the Warburg effect
2025
·
Zhizai Chen
, Dalong Song
, et al.
·
Molecular and Cellular Biochemistry
·
3
A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer
2023
·
Chenfei Zhou
, Junnan Ma
, et al.
·
Biochemical Genetics
·
1
PDF
Global burden of ovarian cancer attributable to high body mass index among women of childbearing age from 1990 to 2021 and projections to 2050: a systematic analysis for the global burden of disease study 2021
2025
·
Hongxi Chen
, Zidan Lin
, et al.
·
Frontiers in Oncology
PDF
Long noncoding RNA BMPR1B-DT promotes anoikis and reduces proliferation in ovarian cancer
2025
·
Yunhui Li
, Xiaojing Chen
, et al.
·
BMC Cancer
Identification of anoikis-related tumor microenvironment characteristics and prognostic signature in ovarian cancer at bulk and single-cell levels
2025
·
Zhenye Tang
, Chenfei Zhou
, et al.
·
Discover Oncology
PDF
Corrigendum to “FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer” [Gynecologic Oncology 127 (2012) 601–610]
2025
·
Shan-yang He
, Hong-wei Shen
, et al.
·
Gynecologic Oncology
PDF
LB006/#1568 Neoadjuvant niraparib monotherapy in homologous recombination deficiency-positive advanced ovarian cancer: a prospective, multicenter, single-arm, phase II study (NANT)
2024
·
Huayi Li
, Dan Liu
, et al.
·
International Journal of Gynecological Cancer
Construction and validation of an anoikis-related gene prognostic signature in ovarian cancer
2023
·
Zhenye Tang
, Shuting Huang
, et al.
·
Research Square
PDF
Correction: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
2023
·
Shanyang He
, Wei Wang
, et al.
·
Oncogenesis
PDF
[Retracted] MicroRNA‑1297 inhibits metastasis and epithelial‑mesenchymal transition by targeting AEG‑1 in cervical cancer
2022
·
Zengyan Wang
, Shanyang He
, et al.
·
Oncology Reports
PDF
Family with sequence similarity 46 member a confers chemo-resistance to ovarian carcinoma via TGF-β/Smad2 signaling
2022
·
Liang, Suiying
, Liu, Yueyang
, et al.
·
Figshare
Show more works
View as search
Works count:
26
Citation count:
399
H-index:
10
I10-index:
11
Year
Topic
Type
